Immunogenicity and safety of inactivated Influenza Split-Virion vaccine administered via a Transdermal Microneedle System
<p>The purpose of the study was to evaluate the immunogenicity and safety of an inactivated influenza split virion vaccine administered via a transdermal microneedle system.</p><p>In this Phase 1, single-center, randomized, controlled study, 90 subjects aged 18 to 40 years receive...
Saved in:
Main Authors: | Mahmoud Ameri (Author), Hayley Lewis (Author), Joe Nguyen (Author) |
---|---|
Format: | Book |
Published: |
Journal of Vaccines and Immunology - Peertechz Publications,
2021-12-13.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity and safety of an intramuscular split-virion quadrivalent inactivated influenza vaccine in individuals aged ≥ 6 months in India
by: Sharad Agarkhedkar, et al.
Published: (2019) -
Immunogenicity and safety of the 2015 Southern Hemisphere formulation of a split-virion inactivated quadrivalent vaccine
by: Cecilia Montalban, et al.
Published: (2018) -
Enhanced passive safety surveillance of a quadrivalent inactivated split virion influenza vaccine in Finland during the influenza season 2020/21
by: Olga Syrkina, et al.
Published: (2022) -
Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18-60 years of age in the Republic of Korea
by: Won Suk Choi, et al.
Published: (2018) -
Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trial
by: Jianmin Chen, et al.
Published: (2023)